Cargando…

Hypertension, glomerular hypertrophy and nephrosclerosis: the effect of race

BACKGROUND: African Americans have more severe hypertensive nephrosclerosis than white Americans, possibly at similar levels of blood pressure. Glomerular volume is increased in African Americans relative to whites, but it is uncertain how this relates to nephrosclerosis and whether it contributes t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hughson, Michael D., Puelles, Victor G., Hoy, Wendy E., Douglas-Denton, Rebecca N., Mott, Susan A., Bertram, John F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	CLINICAL SCIENCE
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071048/ https://www.ncbi.nlm.nih.gov/pubmed/24327566 http://dx.doi.org/10.1093/ndt/gft480

Ejemplares similares

APOL1 Risk Alleles Are Associated With More Severe Arteriosclerosis in Renal Resistance Vessels With Aging and Hypertension
por: Hughson, Michael D., et al.
Publicado: (2016)

Comparison of 6 equations for estimating glomerular filtration rate in a Chinese benign hypertensive nephrosclerosis population
por: Ke, Guibao, et al.
Publicado: (2021)

Clinical Phenotypes and Long-term Prognosis in White Patients With Biopsy-Verified Hypertensive Nephrosclerosis
por: Øvrehus, Marius A., et al.
Publicado: (2019)

APOL1 Risk Variants Independently Associated With Early Cardiovascular Disease Death
por: Hughson, Michael D., et al.
Publicado: (2017)

Towards a definition of glomerulomegaly: clinical–pathological and methodological considerations
por: Hughson, Michael D., et al.
Publicado: (2011)

Effect of Proteinuria and Glomerular Filtration Rate on Renal Outcome in Patients with Biopsy-Proven Benign Nephrosclerosis
por: Sumida, Keiichi, et al.
Publicado: (2016)

Investigation into the underlying molecular mechanisms of hypertensive nephrosclerosis using bioinformatics analyses
por: Liu, Tianlong, et al.
Publicado: (2018)

Effect of Intensive Blood Pressure Control on Cardiovascular Remodeling in Hypertensive Patients with Nephrosclerosis
por: Randall, Otelio, et al.
Publicado: (2013)

Prostacyclin analog beraprost sodium efficacy in primary glomerular disease or nephrosclerosis: Analysis of the Japanese subgroup in CASSIOPEIR study
por: Kurumatani, Hajimu, et al.
Publicado: (2021)

Comparative analysis of hypertensive nephrosclerosis in animal models of hypertension and its relevance to human pathology. Glomerulopathy
por: Gutsol, Alex A., et al.
Publicado: (2022)

Bone Morphogenetic Protein (BMP)-7 expression is decreased in human hypertensive nephrosclerosis
por: Bramlage, Carsten P, et al.
Publicado: (2010)

Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis
por: Momoki, Kumiko, et al.
Publicado: (2017)

Serum Potassium Predicts Time to Blood Pressure Response Among African-Americans with Hypertensive Nephrosclerosis
por: Bhalla, Meeta, et al.
Publicado: (2012)

Tamoxifen associated to the conservative CKD treatment promoted additional antifibrotic effects on experimental hypertensive nephrosclerosis
por: Fanelli, Camilla, et al.
Publicado: (2023)

Progressive Nephron Loss in Aging Kidneys: Clinical–Structural Associations Investigated by Two Anatomical Methods
por: Hughson, Michael D., et al.
Publicado: (2019)

Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study
por: Liang, Shaoshan, et al.
Publicado: (2016)

Adolescent-onset TAFRO Syndrome with Malignant Nephrosclerosis-like Lesions
por: Nakayama, Yuki, et al.
Publicado: (2022)

Influence of variability in the cyclooxygenase pathway on cardiovascular outcomes of nephrosclerosis patients
por: González, Luz M., et al.
Publicado: (2023)

The Renal Protective Effect of Jiangya Tongluo Formula, through Regulation of Adrenomedullin and Angiotensin II, in Rats with Hypertensive Nephrosclerosis
por: Han, Lin, et al.
Publicado: (2015)

Gene Expression Studies and Targeted Metabolomics Reveal Disturbed Serine, Methionine, and Tyrosine Metabolism in Early Hypertensive Nephrosclerosis
por: Øvrehus, Marius A., et al.
Publicado: (2018)

Birthweight and the Prevalence, Progression, and Incidence of CKD in a Multideterminant Model in a High-Risk Australian Aboriginal Community
por: Hoy, Wendy E., et al.
Publicado: (2021)

Postural control in women with breast hypertrophy: Postural control in breast hypertrophy
por: Barbosa, Alessandra Ferreira, et al.
Publicado: (2012)

Machine learning for morbid glomerular hypertrophy
por: Ushio, Yusuke, et al.
Publicado: (2022)

The ability of remaining glomerular podocytes to adapt to the loss of their neighbours decreases with age
por: van der Wolde, James, et al.
Publicado: (2022)

A multinational phase IIb/III trial of beraprost sodium, an orally active prostacyclin analogue, in patients with primary glomerular disease or nephrosclerosis (CASSIOPEIR trial), rationale and study design
por: Nakamoto, Hidetomo, et al.
Publicado: (2014)

Genetic Variants in PGE2 Receptors Modulate the Risk of Nephrosclerosis and Clinical Outcomes in These Patients
por: González, Luz María, et al.
Publicado: (2021)

Transcriptomic analysis reveals partial epithelial–mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathy
por: Nordbø, Ole Petter, et al.
Publicado: (2023)

Glomerular Filtration Rate Measured by (51)Cr-EDTA Clearance: Evaluation of Captopril-Induced Changes in Hypertensive Patients with and without Renal Artery Stenosis
por: Chaves, Anna Alice Rolim, et al.
Publicado: (2010)

HIV and race are independently associated with endothelial dysfunction
por: Mouchati, Christian, et al.
Publicado: (2023)

Tag-SNPs in Phospholipase-Related Genes Modify the Susceptibility to Nephrosclerosis and its Associated Cardiovascular Risk
por: González, Luz M., et al.
Publicado: (2022)

Influence of race in the estimation of glomerular filtration rate in patients with a high cardiovascular and renal risk
por: Ferreira, João Pedro, et al.
Publicado: (2021)

Phlorizin Prevents Glomerular Hyperfiltration but not Hypertrophy in Diabetic Rats
por: Malatiali, Slava, et al.
Publicado: (2008)

Cardiac Biomarkers and Left Ventricular Hypertrophy in Asymptomatic Hemodialysis Patients
por: Koycheva, Reneta Yovcheva, et al.
Publicado: (2016)

A Case of Significant Improvement of Heart Failure With Reduced Ejection Fraction With a Small Dose of Candesartan in a Hemodialysis Patient With Hypertensive Heart Disease and Nephrosclerosis
por: Harada, Haruhito, et al.
Publicado: (2023)

Endothelial-derived complement factor D contributes to endothelial dysfunction in malignant nephrosclerosis via local complement activation
por: Wang, Zheng, et al.
Publicado: (2023)

Predictor variables for half marathon race time in recreational female runners
por: Knechtle, Beat, et al.
Publicado: (2011)

Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study
por: Isenberg, David, et al.
Publicado: (2010)

Sex hormones in Malay and Chinese men in Malaysia: are there age and race differences?
por: Chin, Kok-Yong, et al.
Publicado: (2013)

Variation of the Anthropometric Index for pectus excavatum relative to age, race, and sex
por: Rebeis, Eduardo Baldassari, et al.
Publicado: (2013)

The reduction of serum aminotransferase levels is proportional to the decline of the glomerular filtration rate in patients with chronic kidney disease
por: Sette, Luís Henrique Bezerra Cavalcanti, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uf6tdfu5c2s1h7qoh47gm3feiv